AONC (American Oncology Network) EBIT per Share : $-2.62 (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is American Oncology Network EBIT per Share?

American Oncology Network's EBIT per Share for the three months ended in Dec. 2024 was $0.10. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-2.62.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for American Oncology Network's EBIT per Share or its related term are showing as below:

AONC's 3-Year EBIT Growth Rate is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 8.6
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

American Oncology Network's EBIT for the three months ended in Dec. 2024 was $4 Mil.

American Oncology Network EBIT per Share Historical Data

The historical data trend for American Oncology Network's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Oncology Network EBIT per Share Chart

American Oncology Network Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

2.34

0.19

0.63

-8.39

-0.47

American Oncology Network Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT per Share	Get a 7-Day Free Trial							-2.95	-2.70	-0.04	0.02	0.10

American Oncology Network EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

American Oncology Network's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-17.556	/	37.505
=	-0.47

American Oncology Network's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	3.92	/	41.343
=	0.09

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.62

American Oncology Network (OTCPK:AONC) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

American Oncology Network EBIT per Share Related Terms

Thank you for viewing the detailed overview of American Oncology Network's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

American Oncology Network Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » American Oncology Network Inc (OTCPK:AONC) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

14543 Global Parkway, Suite 110, Fort Myers, FL, USA, 33913

Website

https://www.aoncology.com

American Oncology Network Inc is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. The company pioneers healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. It is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care needed to achieve optimal health outcomes.

Executives

Stephen Divers	director, officer: Chief Medical Officer	133 HARMONY PARK CIRCLE, HOT SPRINGS AZ 71913
Todd Schonherz	director, officer: Chief Executive Officer	14543 GLOBAL PARKWAY, 2ND FLOOR, FORT MEYERS FL 33913
Saba Capital Management, L.p.	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
David H Gould	officer: Chief Financial Officer	7370 COLLEGE PARKWAY, SUITE 207, FORT MEYERS FL 33907
Erica Mallon	officer: General Counsel	14543 GLOBAL PARKWAY, SUITE 110, FORT MEYERS FL 33913
Shalin Shah	director	3402 W DR. MARTIN LUTHER KING JR. BLVD, TAMPA FL 33607
Vipul M Patel	director	11704 SE 15TH CIRCLE, OCALA FL 34480
Vance Wright-browne	director	22395 EDGEWATER DRIVE, PORT CHARLOTTE FL 33980
James Stith	director	ONE LETTERMAN DRIVE, CM200, SAN FRANCISCO CA 94129
Aea Growth Equity Fund Lp	10 percent owner	520 MADISON AVE, 40TH FLOOR, NEW YORK NY 10022
Aea Growth Equity Fund (parallel) Lp	10 percent owner	520 MADISON AVE, 40TH FLOOR, NEW YORK NY 10022
Ravi Yang Sarin	director	C/O ARES MANAGEMENT LLC, 2000 AVENUE OF THE STARS, 12TH FLOOR, LOS ANGELES CA 90067
Brian R Hoesterey	10 percent owner	C/O AEA INVESTORS LP, 666 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10103
Kevin Nazemi	director, officer: Chief Executive Officer	10485 NE 6TH ST, UNIT 3930, BELLEVUE WA 98004